SPONSOR
Mabwell (Shanghai) Bioscience Co., Ltd.
Total Trials
4
Recruiting
4
Phases
Phase 1, Phase 2
Conditions studied: Advanced Malignant Solid TumorsPolycythemia VeraBeta-ThalassemiaUrothelial CarcinomaUrothelial Carcinoma BladderUrothelial Carcinoma RecurrentUrothelial Carcinoma of the Renal Pelvis and Ureter
NCT05773937 Phase 1
Recruiting
A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors
Advanced Malignant Solid Tumors
NCT06752746 Phase 1
Recruiting
A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera
Polycythemia Vera
NCT06772766 Phase 1
Recruiting
A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent β-thalassemia
Beta-Thalassemia
NCT06823427 Phase 2
Recruiting
9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Carcinoma